Perales, Miguel-Angel <br/><br/>
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.  [electronic resource] 

 -  Blood  Dec 2012 
 - 4882-91 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2012-06-437236  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Area Under Curve<br/>CD4-Positive T-Lymphocytes--drug effects<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Cell Proliferation<br/>Combined Modality Therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Gene Rearrangement, T-Lymphocyte<br/>Graft vs Host Disease--chemically induced<br/>Hematologic Neoplasms--immunology<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Interleukin-7--genetics<br/>Interleukin-7 Receptor alpha Subunit--immunology<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Receptors, Antigen, T-Cell--genetics<br/>Recombinant Proteins--adverse effects<br/>T-Lymphocytes--drug effects<br/>Transplantation, Homologous<br/>Treatment Outcome